“Episode 81: How Much Will A Patient Pay for A Drug with AJ Loiacano from Truveris”
by Stacey Richter

Click here to listen

A J Loiacono

A.J. Loiacono is the Chief Innovation Officer at Truveris, where he leads product development, strategic planning and enterprise partnerships. Prior to Truveris, AJ was a co-founder and Partner with SMS, a software development firm specializing in transactional software solutions for national realtors. He also founded enterprise resource planning company, Victrix, leading the firm to a successful sale. AJ previously served as a Partner with Artemis Venture Capital.


00:00 AJ dissects the patient transaction with a pharmacist at the pharmacy.
02:30 The faucets of an insured transaction, and what all of this entails.
04:50 The three entities that 70% of all insured transactions happen through.
05:45 The confusion between medical insurance and pharmacy benefits.
06:00 How self-insured employers fit into this confusion.
08:00 Prior-authorization and how this affects a patient’s access to certain drugs.
09:55 AJ discusses Martin Shkreli and the implications that his actions have had on the healthcare and pharmaceutical industry.
13:45 “I am exposed to cost.”
14:30 How a pharmacy gets reimbursed.
18:00 Walgreens as a learning lesson for other pharmacies.
20:30 Branded drugs vs. Generic drugs, Prescriptions vs. Pharmacy decisions
23:15 Dispense as written codes.
25:00 How plan design can have just as much deciding power as the physician writing the prescription.
28:45 AJ explains Truveris.
30:00 Anyone can download the Truveris app.
31:30 The copay threshold.
34:45 You can find out more at oneRX.com, and truveris.com.

Please subscribe if you enjoyed the episode. Also, consider leaving a rating and review on any of the online players so we can continue to improve our offerings. Thank you for your help.

Click here to subscribe via iTunes   Click here to subscribe via Google Play   Click here to subscribe via Stitcher